Hurst, TX, United States of America

Loretta Graves McNatt

USPTO Granted Patents = 10 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2006-2017

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Loretta Graves McNatt: Innovator in Glaucoma Treatment

Introduction

Loretta Graves McNatt is a distinguished inventor based in Hurst, Texas. She has made significant contributions to the field of medical science, particularly in the treatment of glaucoma. With a total of 10 patents to her name, McNatt has established herself as a leading figure in her area of expertise.

Latest Patents

Among her latest patents is the innovative approach titled "RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma." This patent focuses on utilizing RNA interference to inhibit Frizzled Related Protein-1 mRNA expression. It is particularly aimed at treating patients who have glaucoma or are at risk of developing this condition. This groundbreaking work highlights her commitment to advancing medical treatments.

Career Highlights

Throughout her career, McNatt has worked with prominent companies such as Alcon, Inc. and Novartis AG. Her experience in these organizations has allowed her to collaborate with some of the brightest minds in the industry.

Collaborations

Some of her notable coworkers include Abbot F. Clark and Wan-Heng Wang. Their collaborative efforts have contributed to the success of her innovative projects.

Conclusion

Loretta Graves McNatt's work in the field of glaucoma treatment exemplifies her dedication to innovation and medical advancement. Her patents and collaborations reflect her significant impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…